CTC Bio Inc (060590) Stock Price & News

060590:KOSDAQ

CTC Bio Inc

₩2,610.00

+0.58%

(+15.00) 1D

Nov 4, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 060590...

Open

₩2,595

High

₩2,650

Low

₩2,525

Mkt. cap

63.11B

Avg. vol.

37.77K

Volume

36.33K

P/E ratio

8.30

52-wk high

₩5,610

52-wk low

₩2,525

EPS

₩314

Shares outstanding

24.18M

No. of employees

226

Open

₩2,595

High

₩2,650

Low

₩2,525

Mkt. cap

63.11B

Avg. vol.

37.77K

Volume

36.33K

P/E ratio

8.30

52-wk high

₩5,610

52-wk low

₩2,525

EPS

₩314

Shares outstanding

24.18M

No. of employees

226

Related stocks

Eagle Veterinary Technology Co Ltd

₩2,975.00

-1.82%

News stories

From web sources and news partners

FinancialContent

30 minutes ago

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

shattered.io

37 minutes ago

S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]

Quantisnow

56 minutes ago

/C O R R E C T I O N - SVRN, Inc./

MarketWatch

1 hour ago

Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress

About CTC Bio Inc

CEO-

Employees226

Founded1993

Headquarters-

SectorPharmaceutical industry

Industry-

Websitectcbio.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	31.80B	31.62B	34.44B	33.69B
Cost of goods sold	19.35B	18.91B	20.10B	20.42B
Cost of revenue	19.35B	18.91B	20.10B	20.42B
Research and development expenses	427.62M	482.35M	205.61M	198.23M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	10.33B	10.29B	9.30B	8.87B
Operating expense	11.00B	11.20B	9.74B	9.48B
Total operating expenses	30.35B	30.11B	29.84B	29.89B
Operating income	1.45B	1.51B	4.60B	3.79B
Other non operating income	-33.35M	-91.96M	-55.25M	-271.27K
EBT including unusual items	1.01B	-220.58M	4.46B	3.49B
EBT excluding unusual items	943.91M	-84.63M	4.38B	3.38B
Income tax expense	656.08M	-1.34B	955.92M	887.77M
Effective tax rate	64.69%	607.65%	21.45%	25.44%
Other operating expenses	109.16M	92.32M	34.12M	202.89M
Net income	310.40M	1.10B	3.50B	2.60B
Net profit margin	0.98%	3.48%	10.16%	7.72%
Earnings per share	-	-	-	-
Interest and investment income	60.95M	94.40M	73.22M	73.88M
Interest expense	-604.79M	-569.99M	-553.03M	-563.90M
Net interest expenses	-543.84M	-475.58M	-479.80M	-490.02M
Depreciation and amortization charges	216.74M	200.89M	174.51M	175.71M
EBITDA	3.07B	3.11B	6.17B	5.38B
Gain or loss from assets sale	-94.40M	-132.54M	-78.68M	-117.11M

Finance

Ask anything